beta-Adrenergic blocking agents in the post-myocardial infarction patient.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003645:Death, Sudden; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011433:Propranolol